Donna Depalmo-Wilson
Women's Health · Orlando, FLNPI 1306356498
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 41.2% of the total. Reporting peaked in 2022 at $932 and has fallen 83.9% since, to $150 in 2025. Among women's health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sumitomo Pharma America, Inc.$277
- Exeltis, USA Inc.$173
- Urovant Sciences Inc$152
- Revance Therapeutics, Inc.$150
- Mayne Pharma Commercial LLC$140
- plus $852 from 14 others
What the payments were for
- Food & beverage$2,958100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $1,220 |
| Sumitomo Pharma America, Inc. | 18 | $277 |
| Exeltis, USA Inc. | 10 | $173 |
| Urovant Sciences Inc | 7 | $152 |
| Revance Therapeutics, Inc. | 1 | $150 |
| Mayne Pharma Commercial LLC | 7 | $140 |
| Mylan Pharmaceuticals Inc. | 7 | $127 |
| Therapeuticsmd, Inc. | 8 | $117 |
| Astellas Pharma US Inc | 5 | $104 |
| Coopersurgical, Inc. | 4 | $90 |
| Exact Sciences | 3 | $70 |
| Hologic Sales And Service, LLC | 4 | $64 |
| Organon | 3 | $49 |
| Pfizer | 3 | $48 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Bayer | 2 | $35 |
| Evofem Biosciences, Inc. | 2 | $33 |
| Axonics, Inc. | 1 | $27 |
| 180 Medical, Inc. | 1 | $24 |
| Scynexis, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$150
How this compares
$2,963 in reported general payments places this provider in the 90th percentile of 308 women's health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $2,630 |
| ValacyclovirValacyclovir Hcl | 21 | $428 |
| Clobetasol Propionate | 20 | $259 |
Paid to pharmacies, not to this prescriber.
Other women's health in Orlando
- Nicole HoffmanOrlando$3K
- Nicole JimenezOrlando$2K
- Danielle JaegerOrlando$1K
- Nancy GalyonJupiter$146K
- Nicole NeidhartJacksonville$23K
- Miok RayTampa$11K
- Michelle McCloskyMiami Beach$11K
- Dalya YebraMiami$8K
- Martha PereiraMiami$7K
- Stacey HallJacksonville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.